• Rain Therapeutics Appoints Chief Science Officer contractpharma
    September 16, 2020
    ​Rain Therapeutics Inc., a privately-held, clinical stage biotechnology company, has appointed Rain co-founder Robert Doebele, MD, PhD, as chief scientific officer (CSO).
PharmaSources Customer Service